Agios Pharmaceuticals
AGIO
#5125
Rank
โ‚น162.43 B
Marketcap
โ‚น2,731
Share price
-0.55%
Change (1 day)
-7.37%
Change (1 year)

Earnings for Agios Pharmaceuticals (AGIO)

Earnings in 2026 (TTM): -โ‚น42.48 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น66.04 Million. In 2025 the company made an earning of -โ‚น44.9 Billion a decrease over its 2024 earnings that were of -โ‚น40.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agios Pharmaceuticals from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น42.48 Billion-5.41%
2025 -โ‚น44.9 Billion10.9%
2024 -โ‚น40.49 Billion8.75%
2023 -โ‚น37.24 Billion0.63%
2022 -โ‚น37 Billion2.81%
2021 -โ‚น35.99 Billion10.58%
2020 -โ‚น32.55 Billion-18.41%
2019 -โ‚น39.9 Billion15.72%
2018 -โ‚น34.48 Billion12.99%
2017 -โ‚น30.51 Billion59.61%
2016 -โ‚น19.12 Billion69.32%
2015 -โ‚น11.29 Billion119.28%
2014 -โ‚น5.15 Billion39.22%
2013 -โ‚น3.7 Billion69.1%
2012 -โ‚น2.19 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.007 T-2,327.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.959 T-6,645.36%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น952.08 B-2,205.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
-โ‚น13.13 Billion-70.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น95.40 B-310.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น36.66 B-181.09%๐Ÿ‡บ๐Ÿ‡ธ USA